GGrantIndex
Sort

27,075 grants matching cholesterol

Filtration Media for In-Home PFAS Removal from Drinking Water

$767,415
Steven D Dietz · Tda Research, Inc. · R44 · FY2024 · ES

Physiological and therapeutic effects of ANGPTL3 variants in mice and humans

$767,297
Marina Cuchel · University Of Pennsylvania · R01 · FY2020 · HL

Alimentary Tract Lipids in Health and Disease

$767,165
Martin Conrad Carey · Brigham And Women'S Hospital · R37 · FY2008 · DK

ApoE2 and protective molecular signatures in Alzheimer's disease and aging

$767,155
Alexander M Kulminski · Duke University · R01 · FY2020 · AG

ApoE2 and protective molecular signatures in Alzheimer's disease and aging

$767,155
Alexander M Kulminski · Duke University · R01 · FY2022 · AG

ApoE2 and protective molecular signatures in Alzheimer's disease and aging

$767,155
Alexander M Kulminski · Duke University · R01 · FY2021 · AG

Interactive Tele-Pharmacy to Improve Chronic Medication Adherence

$767,075
Niteesh K Choudhry · Brigham And Women'S Hospital · R01 · FY2017 · HL

Effects of a Novel, Scalable, and Sustainable Patient Portal Intervention on Diabetes-Related Outcomes: A Pragmatic Randomized Controlled Trial

$766,842
William Martinez · Vanderbilt University Medical Center · R01 · FY2021 · DK

Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery

$766,601
James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR

Familial hypercholesterolemia screening in children: population impact of phenotype, genotype, and cascade approaches

$766,330
Andrew Edward Moran · Columbia University Health Sciences · R01 · FY2022 · HL

Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat

$766,182
Donna K. Arnett · University Of Kentucky · R01 · FY2018 · HL

Imaging the Vascular Consequences of Lipid Deposition

$766,138
James Athur Hamilton · Boston University Medical Campus · P50 · FY2010 · HL

Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism

$766,124
Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2017 · AA

Koli: A non-surgical solution for gallstone disease

$766,033
Christopher Cheng · Koli, Inc. · R44 · FY2024 · DK

Allopregnanolone a Regenerative Therapy for Alzheimer's: FDA-Required Toxicolog

$765,963
Roberta Diaz Brinton · University Of Southern California · U01 · FY2016 · AG

Early life stress and cardiometabolic health in adolescence

$765,927
Megan R Gunnar · University Of Minnesota · R01 · FY2022 · HL

A Novel Mouse Model of Obesity in Pregnancy

$765,915
Thomas Jansson · University Of Colorado Denver · R24 · FY2016 · OD

Per- and polyfluoroalkyl substances, apolipoproteins, and risk of coronary heart disease

$765,745
Qi Sun · Brigham And Women'S Hospital · R01 · FY2024 · ES

Randomized Trial of CVD Education and Problem-Solving Training in Urban Diabetics

$765,653
Felicia Hill-Briggs · Johns Hopkins University · R01 · FY2012 · HL

GENETIC EPIDEMIOLOGY OF CORONARY ARTERY DISEASE

$765,571
University Of Michigan At Ann Arbor · R01 · FY2000 · HL

Human Atherogenesis with Underlying Dysfunctional HDL-Free Cholesterol

$765,547
Henry J. Pownall · Methodist Hospital Research Institute · R01 · FY2023 · HL

ABCD-USA Consortium: Coordinating Center

$765,000
Terry L Jernigan · University Of California, San Diego · U24 · FY2023 · DA

Dietary Fat and HDL Metabolism

$764,848
Frank M Sacks · Harvard School Of Public Health · R01 · FY2011 · HL

Mitochondrial DNA heteroplasmy and risk for atherosclerotic cardiovascular disease (ASCVD)

$764,811
Dan E Arking · Johns Hopkins University · R01 · FY2021 · HL

Epigenetic roles in regulation of cholesterol metabolism and CVD risk

$764,754
Yongmei Liu · Wake Forest University Health Sciences · R01 · FY2016 · HL